Advertisement

Life-Sciences-Asia.com
The East-West Life Sciences Web Portal
This is a free web portal for the life sciences in Asia-Pacific, Europe and North America... » read more
- Stryker to Sell US Spinal Implants Business (2025-01-28)
Stryker (NYSE:SYK), a global leader in medical technologies, announced today a definitive agreement to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC, a family-owned investment firm specializing in the neuro-musculoskeletal space, to create a n... - SGS Is in Discussions with Bureau Veritas Regarding Merger (2025-01-15)
Ad hoc announcement pursuant to Art. 53 LR Statement Following recent media commentary SGS indicates that it is in discussions with Bureau Veritas regarding a potential business combination. There can be no assurance that these discussions will result in a ... - Eckert & Ziegler Licences Cyclotron Technology to Chinese JV (2025-01-14)
Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) today signed a licence agreement with Qi Kang Medical, Ltd (QKM), a joint venture between Eckert & Ziegler and the Chinese company DC Pharma, for the cyclotron technology used by Eckert & Ziegler to manufacture Ac-225... - Bioptimus Raises $41m Round Led by Cathay Innovation (2025-01-14)
> Bioptimus announces a $76M funding milestone, with the latest injection of $41M led by Cathay Innovation less than 12 months from its initial seed round > Since the successful release of the largest AI foundation model for pathology in July, the company has be... - BioMed X & Daiichi Sankyo Launch New Cancer Collaboration (2025-01-14)
German research institute BioMed X started a new partnership with Daiichi Sankyo, a Japanese pharmaceutical company, to advance the development of bi- and multi-specific biologics for treating solid tumors. BioMed X, an independent biomedical research institut... - Umoja Biopharma Closes Oversubscribed $100m Series C Round (2025-01-14)
> Series C financing co-led by Double Point Ventures and DCVC Bio > Proceeds to support the clinical development of VivoVec™ derived in vivo CAR T cells Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo cell therapies that aim to realize... - Daiichi Sankyo Acquires Ab IP from Glycotope for $132.5m (2025-01-13)
Daiichi Sankyo Company, Ltd (TSE: 4568) announced today that it will pay Glycotope $132.5 million to acquire intellectual property rights of the anti-tumor-associated mucin-1 (TA-MUC1) antibody, gatipotuzumab. Such payment by Daiichi Sankyo satisfies all potential ... - Normunity Closes $75m Series B Financing Round (2025-01-13)
> Financing co-led by Samsara Biocapital and Enavate Sciences, with participation from Pfizer Ventures and Regeneron Ventures in addition to other new and existing investors > Normunity’s lead program is a novel T cell engager against a tumor-specific target t... - Candid Tx Licenses Trispecific T-cell Engager from WuXi (2025-01-13)
Candid Therapeutics, Inc. (“Candid”), a clinical-stage biotechnology company focused on becoming the leader in advancing T-cell engagers for autoimmune and inflammatory diseases, announced today an agreement with WuXi Biologics under which Candid will have excl... - Eckert & Ziegler & GlyTherix Extend Ac-225 Supply Agreement (2025-01-13)
Eckert & Ziegler (ISIN DE0005659700, SDAX) and GlyTherix Ltd (GlyTherix), an Australian targeted radiotherapy company specialising in developing antibody radiopharmaceuticals for solid tumors, today announced the expansion of their existing Lutetium-177 based colla...
Life-Sciences-Asia.com is your doorway to the East-West life sciences!
[LSA] provides free, up-to-date and structured access to
– News
– Products
– Persons
– Organisations
– Financings
– Collaborations
in the Asia-Pacific, Europe and North America regions.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSA] is 100% Made in Europe!
» Start here with the latest News!Advertisement

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top